TransDigm Group
TDG NYSE Aerospace & Defense Financials FY2016βFY2025
TransDigm Group's revenue rose 11.2% to $8.8 billion in fiscal 2025. Its operating margin was 47.2%, up from 44.5% a year earlier. Free cash flow was $1.8 billion, down 3.4%. It paid out $659 million in dividends and buybacks, 36% of free cash flow. The diluted share count rose 0.7%.
What TransDigm Group does
No business description yet.
- Legal name
- TransDigm Group Incorporated
- Fiscal year ends
- September 30, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001260221-25-000081
0001260221
Revenue and margins
TransDigm Group had $8.8B of revenue in fiscal 2025, up 11.2% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 13.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.8B in fiscal 2025, 20.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
TransDigm Group returned $659M to shareholders in fiscal 2025, 36% of free cash flow. The diluted share count rose 0.7%.
Value TransDigm Group yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$26.8B and divides by 58.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 33.5x Β· peers 23.5x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably TransDigm Group can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $4.8B | $3.0B | $3.5B | $6.3B | $2.8B |
| Debt incl. finance leases | $19.7B | $19.6B | $19.6B | $24.7B | $29.6B |
| Net debt / EBITDA | 7.7x | 6.7x | 5.1x | 4.8x | 5.9x |
| Interest coverage | 1.7x | 2.1x | 2.5x | 3.1x | 2.8x |
| Current ratio | 4.2x | 4.0x | 4.3x | 1.6x | 3.2x |
| Quick ratio | 3.5x | 3.0x | 3.2x | 1.3x | 2.3x |
| Total assets | $19.3B | $18.1B | $20.0B | $25.6B | $22.9B |
| Total liabilities | $22.2B | $21.9B | $21.9B | $31.9B | $32.6B |
| Shareholders' equity | β$2.9B | β$3.8B | β$2.0B | β$6.3B | β$9.7B |
| Net debt (β = net cash) | $15.0B | $16.6B | $16.1B | $18.4B | $26.8B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$91.0M
2 insiders
Of sales under plans
80%
$72.6M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Joel ReissCo-Chief Operating Officer | Sold plan | 4,100 | $1,128.04 | $4.6M | Form 4 |
| Sep 15, 2026 | Joel ReissCo-Chief Operating Officer | Sold plan | 3,900 | $1,094.58 | $4.3M | Form 4 |
| Aug 18, 2026 | Howley W NicholasDirector | Sold plan | 10,132 | $1,236.27 | $12.5M | Form 4 |
| Aug 17, 2026 | Joel ReissCo-Chief Operating Officer | Sold plan | 3,900 | $1,238.76 | $4.8M | Form 4 |
| Jul 20, 2026 | Howley W NicholasDirector | Sold plan | 10,132 | $1,216.08 | $12.3M | Form 4 |
| Jul 15, 2026 | Joel ReissCo-Chief Operating Officer | Sold plan | 3,486 | $1,216.21 | $4.2M | Form 4 |
| Jul 15, 2026 | Joel ReissCo-Chief Operating Officer | Sold plan | 414 | $1,231.11 | $0.5M | Form 4 |
| Jun 18, 2026 | Howley W NicholasDirector | Sold | 10,132 | $1,319.55 | $13.4M | Form 4 |
| Jun 15, 2026 | Joel ReissCo-Chief Operating Officer | Sold | 3,900 | $1,276.78 | $5.0M | Form 4 |
| May 18, 2026 | Howley W NicholasDirector | Sold plan | 10,132 | $1,180.82 | $12.0M | Form 4 |
| May 15, 2026 | Joel ReissCo-Chief Operating Officer | Sold plan | 3,900 | $1,154.09 | $4.5M | Form 4 |
| Apr 20, 2026 | Howley W NicholasDirector | Sold plan | 10,132 | $1,265.06 | $12.8M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 9 / 9 | 6 / 9 | 4 / 9 |
| Accruals ratio | β0.4% | β1.5% | 0.2% |
| Altman Z'' | 2.16 | 0.73 | 0.78 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| TransDigm Group TDG | $63.4B | 11.2% | 47.2% | 20.6% | 22.5% | 33.5x | 4 | |
| Howmet Aerospace HWM | $74.7B | 11.1% | 24.8% | 17.3% | 22.4% | 40.1x | 7 | Compare β |
| Elbit Systems ESLT | $34.5B | 16.3% | 8.5% | 7.0% | 18.0% | β | 8 | Compare β |
| Parsons PSN | $5.3B | β5.7% | 6.6% | 6.5% | 9.8% | 23.5x | 7 | Compare β |
| Huntington Ingalls Industries HII | $10.8B | 8.2% | 5.3% | 6.4% | 7.3% | 16.3x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.2B | $3.5B | $3.8B | $5.2B | $5.1B | $4.8B | $5.4B | $6.6B | $7.9B | $8.8B |
| Gross profit | $1.7B | $2.0B | $2.2B | $2.8B | $2.6B | $2.5B | $3.1B | $3.8B | $4.7B | $5.3B |
| Research and development | $58.6M | $73.8M | $73.8M | $117M | $131M | $106M | $95.0M | $105M | $107M | $118M |
| Operating income | $1.3B | $1.5B | $1.7B | $1.9B | $1.8B | $1.7B | $2.2B | $2.9B | $3.5B | $4.2B |
| Interest expense | $449M | $588M | $635M | $878M | $923M | $1.0B | $1.1B | $1.2B | $1.2B | $1.5B |
| Pretax income | $768M | $837M | $986M | $1.1B | $740M | $715M | $1.1B | $1.7B | $2.2B | $2.6B |
| Income tax | $182M | $209M | $24.0M | $222M | $87.0M | $34.0M | $261M | $417M | $500M | $555M |
| Net income | $586M | $597M | $957M | $890M | $699M | $680M | $866M | $1.3B | $1.7B | $2.1B |
| Diluted EPS | $10.39 | $7.88 | $16.20 | $13.84 | $8.96 | $10.41 | $13.40 | $22.03 | $25.62 | $32.08 |
| Diluted shares | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | $683M | $789M | $1.0B | $1.0B | $1.2B | $913M | $948M | $1.4B | $2.0B | $2.0B |
| Capital expenditure | $44.0M | $71.0M | $73.0M | $102M | $105M | $105M | $119M | $139M | $165M | $222M |
| Free cash flow | $639M | $718M | $949M | $913M | $1.1B | $808M | $829M | $1.2B | $1.9B | $1.8B |
| Depreciation and amortization | $122M | $141M | $129M | $226M | $283M | $253M | $253M | $268M | $312M | $367M |
| Stock-based compensation | $48.3M | $45.5M | $58.5M | $93.0M | $93.0M | $129M | $153M | $135M | $188M | $152M |
| Acquisitions | $1.4B | $216M | $668M | $4.0B | $0.0M | $963M | $437M | $762M | $2.3B | $419M |
| Share buybacks | $208M | $390M | $0.0M | $0.0M | $19.0M | $0.0M | $912M | $0.0M | $0.0M | $500M |
| Dividends paid | $3.0M | $2.6B | $56.0M | $1.7B | $1.9B | $73.0M | $1.1B | $38.0M | $2.0B | $159M |
| Dividends and buybacks | $211M | $3.0B | $56.0M | $1.7B | $1.9B | $73.0M | $2.0B | $38.0M | $2.0B | $659M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $1.6B | $651M | $2.1B | $1.5B | $4.7B | $4.8B | $3.0B | $3.5B | $6.3B | $2.8B |
| Total debt | $10.0B | $11.5B | $12.6B | $16.5B | $19.7B | $19.6B | $19.4B | $19.4B | $24.4B | $29.3B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $57.0M | $100M | $146M | $193M | $262M | $284M |
| Current assets | $2.9B | $2.1B | $3.7B | $4.9B | $7.0B | $7.0B | $5.6B | $6.7B | $10.0B | $7.0B |
| Current liabilities | $753M | $871M | $900M | $1.5B | $1.6B | $1.7B | $1.4B | $1.6B | $6.3B | $2.2B |
| Inventory | $724M | $731M | $805M | $1.2B | $1.3B | $1.2B | $1.3B | $1.6B | $1.9B | $2.1B |
| Property and equipment, net | $311M | $325M | $388M | $757M | $752M | $770M | $807M | $1.3B | $1.5B | $1.6B |
| Total assets | $10.7B | $10.0B | $12.2B | $16.3B | $18.4B | $19.3B | $18.1B | $20.0B | $25.6B | $22.9B |
| Total liabilities | $11.4B | $12.9B | $14.0B | $19.1B | $22.4B | $22.2B | $21.9B | $21.9B | $31.9B | $32.6B |
| Shareholders' equity | β$652M | β$3.0B | β$1.8B | β$2.9B | β$4.0B | β$2.9B | β$3.8B | β$2.0B | β$6.3B | β$9.7B |
| Margins | ||||||||||
| Gross margin | 54.5% | 56.6% | 57.1% | 53.8% | 51.9% | 52.4% | 57.1% | 58.3% | 58.8% | 60.1% |
| Operating margin | 40.0% | 42.3% | 43.4% | 36.9% | 34.3% | 35.2% | 40.8% | 44.4% | 44.5% | 47.2% |
| EBITDA margin | 43.8% | 46.3% | 46.8% | 41.2% | 39.9% | 40.5% | 45.5% | 48.5% | 48.4% | 51.3% |
| Net margin | 18.5% | 17.0% | 25.1% | 17.0% | 13.7% | 14.2% | 16.0% | 19.7% | 21.6% | 23.5% |
| FCF margin | 20.2% | 20.5% | 24.9% | 17.5% | 21.7% | 16.8% | 15.3% | 18.8% | 23.7% | 20.6% |
| Returns | ||||||||||
| Return on capital | 13.7% | 14.3% | 19.5% | 14.6% | 13.3% | 14.0% | 13.7% | 16.4% | 20.8% | 22.5% |
| Return on capital employed | 14.4% | 15.5% | 16.2% | 14.8% | 11.1% | 9.8% | 12.9% | 16.7% | 18.8% | 20.8% |
| Return on assets | 6.2% | 5.8% | 8.6% | 6.3% | 4.0% | 3.6% | 4.6% | 6.8% | 7.5% | 8.6% |
| Growth | ||||||||||
| Revenue growth | 17.2% | 10.5% | 8.8% | 37.1% | β2.3% | β6.0% | 13.2% | 21.3% | 20.6% | 11.2% |
| Net income growth | 31.1% | 1.8% | 60.3% | β7.0% | β21.5% | β2.7% | 27.4% | 49.9% | 32.1% | 21.0% |
| EPS growth | 32.5% | β24.2% | 105.6% | β14.6% | β35.3% | 16.2% | 28.7% | 64.4% | 16.3% | 25.2% |
| FCF growth | 37.2% | 12.3% | 32.2% | β3.8% | 21.4% | β27.1% | 2.6% | 49.1% | 52.1% | β3.4% |
| Share count change | β0.8% | β1.1% | 0.1% | 1.3% | 1.8% | 1.9% | β0.3% | β1.7% | 1.1% | 0.7% |
| Financial health | ||||||||||
| Net debt / EBITDA | 6.1x | 6.7x | 5.9x | 7.0x | 7.4x | 7.7x | 6.7x | 5.1x | 4.8x | 5.9x |
| Interest coverage | 2.8x | 2.5x | 2.6x | 2.2x | 1.9x | 1.7x | 2.1x | 2.5x | 3.1x | 2.8x |
| Current ratio | 3.9x | 2.5x | 4.1x | 3.2x | 4.3x | 4.2x | 4.0x | 4.3x | 1.6x | 3.2x |
| Quick ratio | 2.9x | 1.6x | 3.2x | 2.4x | 3.5x | 3.5x | 3.0x | 3.2x | 1.3x | 2.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.4% | 2.0% | 1.9% | 2.0% | 2.1% | 2.2% | 2.2% | 2.1% | 2.1% | 2.5% |
| Stock comp / revenue | 1.5% | 1.3% | 1.5% | 1.8% | 1.8% | 2.7% | 2.8% | 2.1% | 2.4% | 1.7% |
| Payouts / FCF | 33.0% | 414.0% | 5.9% | 187.5% | 175.7% | 9.0% | 241.6% | 3.1% | 108.4% | 36.3% |
| Quality scores | ||||||||||
| Piotroski F-score | 8.0 | 5.0 | 7.0 | 4.0 | 5.0 | 5.0 | 8.0 | 9.0 | 6.0 | 4.0 |
| Altman Z'' | 1.7 | 0.6 | 1.7 | 1.4 | 1.6 | 1.7 | 1.5 | 2.2 | 0.7 | 0.8 |
| Accruals ratio | β1.0% | β1.9% | β0.6% | β0.9% | β3.0% | β1.2% | β0.4% | β0.4% | β1.5% | 0.2% |
Source: SEC EDGAR XBRL filings (CIK 0001260221). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.